Pages that link to "Q41822506"

The following pages link to Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase (Q41822506):

Displaying 17 items.

• How Mouse Macrophages Sense What Is Going On. (Q26745544) (← links)
• Leukocyte homing, fate, and function are controlled by retinoic acid (Q26865933) (← links)
• Seeing through the dark: New insights into the immune regulatory functions of vitamin A (Q27006525) (← links)
• Location, location, location: tissue-specific regulation of immune responses (Q27009106) (← links)
• 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity (Q27012963) (← links)
• CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses (Q28072933) (← links)
• The Roles of CD137 Signaling in Atherosclerosis (Q28076613) (← links)
• Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies (Q28656460) (← links)
• TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation (Q34289268) (← links)
• Dendritic cell-epithelial cell crosstalk in the gut. (Q35190718) (← links)
• Can we produce true tolerance in patients with food allergy? (Q37253374) (← links)
• Programming the immune checkpoint to treat hematologic malignancies. (Q38806070) (← links)
• Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties (Q39616830) (← links)
• Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand (Q42364296) (← links)
• 4-1BB ligand signaling to T cells limits T cell activation (Q43074668) (← links)
• CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice (Q48340513) (← links)
• An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses (Q97654005) (← links)